Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibodytherapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.

Therapeutics

Health Care

Biotechnology

Orum Therapeutics

SJ Lee

Susan B.

Peter U. Park

Olaf Christensen

Greg Dwyer

The Leadership Team at Orum Therapeutics provides strategic direction and oversight, ensuring alignment between the company's scientific innovations and business objectives. This team, comprising key executives such as the Chief Scientific Officer, CEO, Chief Medical Officer, Vice President of Global Human Resources, and Senior Vice President of Business Development, drives the development of Orum's groundbreaking antibody platform, steers corporate growth, and fosters a collaborative, productive organizational culture.

Leadership Team

Operations Team

Scientific Research Team

Leadership Team

About

Team members

Other teams at Orum Therapeutics

Operations Team

Scientific Research Team